About Vernal
Vernal is a company based in New York (United States) founded in 2010 was acquired by Orioninc in March 2017. Vernal operates in a competitive market with competitors including Aqemia, NTxBio, Nimble Therapeutics, Applied BioMath and IMIDomics, among others.
- Headquarter New York, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Vernal
Investors in Vernal
Vernal has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Orioninc and Potomac Equity Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Potomac Equity Partners is engaged in private equity investments.
|
Founded Year | Domain | Location | |
|
Provider of AI, data analytics, application development and IT security services
|
Founded Year | Domain | Location |
Investments & Acquisitions by Vernal
Financial Statements - Vernal
Vernal Comparisons
Competitors of Vernal
Vernal operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aqemia, NTxBio, Nimble Therapeutics, Applied BioMath and IMIDomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutic molecules are discovered through AI and quantum physics integration.
|
|
| domain | founded_year | HQ Location |
Provider of bio informatics platform to develops biologics and therapeutics
|
|
| domain | founded_year | HQ Location |
Combinatorial chemistry services for peptide-based drug discovery are provided.
|
|
| domain | founded_year | HQ Location |
Systems biology and pharmacology modeling services to aid drug discovery and development
|
|
| domain | founded_year | HQ Location |
Precision medicines for immune-mediated inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Software solutions for computational chemistry are developed and provided.
|
Latest news on Vernal
Frequently Asked Questions about Vernal
Vernal was founded in 2010.
Vernal is headquartered in New York, United States. It is registered at New York, New York, United States.
Vernalis was founded in 2010 and is headquartered in New York, United States. Operations focus on the biotechnology sector, where a specialized platform for fragment and structure-based drug discovery is utilized. Services encompass early-stage research tools and methodologies to support pharmaceutical development. The company operates primarily in the United States, aiding clients in identifying potential drug candidates through advanced structural analysis techniques.
Vernal has 2 investors. Key investors include Orioninc, and Potomac Equity Partners.